May 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2019 Mar 31, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 18 mln 0 mln 1.01
(-98.7 pct)
Operating loss 479 mln loss 298 mln loss 650 mln
Recurring loss 484 mln loss 310 mln loss 656 mln
Net loss 467 mln loss 292 mln loss 643 mln
EPS loss 45.01 yen loss 31.13 yen loss 58.29 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T